Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy

Altered number, subset composition, and function of bone marrow innate lymphoid cells are early events in monoclonal gammopathies. Pomalidomide therapy leads to reduction in Ikzf1 and Ikzf3 and enhanced human innate lymphoid cell function in vivo.

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood Adv
Main Authors: Kini Bailur, Jithendra, Mehta, Sameet, Zhang, Lin, Neparidze, Natalia, Parker, Terri, Bar, Noffar, Anderson, Tara, Xu, Mina L., Dhodapkar, Kavita M., Dhodapkar, Madhav V.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2017
Teme:
Stimulus Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729633/
https://ncbi.nlm.nih.gov/pubmed/29296884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017012732
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki